DNMT3A and pachyonychia congenita: DNMT3A induced the hypermethylation of the SOCS2 promoter and then activated STAT5 activities, thereby promoting PC tumorigenesis, whereas the overexpression of miR-532-3p suppressed PC progression in vitro and in vivo through the DNMT3A/SOCS2 axis.